Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
The Effect of a Probiotic Preparation (VSL#3) Plus Infliximab in Children With Crohn's Disease
This study is currently recruiting participants.
Verified March 2012
by Samsung Medical Center
Study NCT01548014 Information provided by Samsung Medical Center
First Received on February 17, 2012. Last Updated on March 7, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Crohn's Disease
Additional conditions recognized in this trial
Crohn Disease
More general conditions related to this trial
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Inflammatory Bowel Diseases
Intestinal Diseases
Interventions listed in this trial
VSL#3
Additional drug interventions recognized in this trial
Infliximab
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antirheumatic Agents
Dermatologic Agents
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Samsung Medical Center
Back to top of Main Content